Susan Hasty, Publisher
Table of Contents . . . October 3rd, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Gene Therapy Weekly | Other Publications
Liver Grafting - Therapy smoothes way for reperfusion in steatotic liver transplantation
Pancreatic Cancer - Bax gene therapy promotes apoptosis in pancreatic cancer cells
Cell Biology - Targeting enzymes that immortalize cancer cells: If they can't be turned off, try to round them up
Corneal Injury - Gene therapy suppresses neovascularization to improve ocular environment
Hemophilia B - Human blood clotting factor achieves sustained levels in rhesus macaques
Neonatology - Bone marrow cells may contribute to growth of new blood vessels in newborns
Bladder Cancer - Antisense technology may help reverse cisplatin-resistance
Cancer Gene Therapy - Technique combines bioreductive chemotherapy and hypoxia-directed gene therapy
DNA Vaccines - DNA Vaccine vector induces IFN-alpha production in pigs
Diabetes Gene Therapy - Liver a promising target for in vivo expression of processed insulin
Diabetes Research - Role of PPAR-gamma in mature 3T3-L1 adipocytes elucidated
Drug Discovery - Quark gets patent relating to secreted and membranal proteins
Gene Delivery - Intracoronary delivery of naked plasmid DNA appears safe, practical
Gene Delivery - Targeted transgene insertion by AAV vectors can aid gene therapy, genomics
Gene Transfer - Lipid-based reagents can offer more efficient transfection
Ischemia - Protein signaling restores vascularity in ischemia-marred limbs
Myocarditis - Type I interferon gene therapy protects against CMV-induced condition
Neovascularization - eNOS overexpression induces angiogenesis in co-culture model
Patents - Broad patent covers oncolytic virus therapies
Restructuring - RPI realigns and restructures; reports Q2 results
Ribozyme Pharmaceuticals, Inc. - Prime Synthesis licenses solid support technology from Ribozyme
Severe Combined Immunodeficiency - Cured of immune disorder, Dutch boy leaves protective bubble
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.